Titan Pharmaceuticals, Inc.
Titan Pharmaceuticals, Inc. (TTNP) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · TTNP · as of Jun 8, 2026
Key Statistics
Explore Titan Pharmaceuticals, Inc. Data
ttnp stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 4 · Buy rate: 50.0%
Competitors & Peers
ttnp competitorsTTNP
CANF
CMND
CNSP
ENSC
KZIAStock Performance
Full HistoryAbout Titan Pharmaceuticals, Inc.
Titan Pharmaceuticals, Inc. is a pharmaceutical company dedicated to creating treatments for chronic conditions, with its product development centered around ProNeura, a unique platform designed for e…
what is titan pharmaceuticals, inc. · ttnp stock overview · titan pharmaceuticals, inc. company profile · who is titan pharmaceuticals, inc. ceo · ttnp NASDAQ · titan pharmaceuticals, inc. headquarters · titan pharmaceuticals, inc. business segments
About Stock Overview & Key Data
Titan Pharmaceuticals, Inc. (TTNP) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jan 18, 1996. As of the latest trading session, TTNP stock price is $2.34, with a market capitalization of $3.1M. The stock has returned -28.66% over the past 12 months and +27.87% year-to-date.
According to 4 Wall Street analysts, the consensus rating for Titan Pharmaceuticals, Inc. stock is Buy, with an average 12-month price target of $—. In fiscal year 2024, Titan Pharmaceuticals, Inc. reported revenue of — and net income of -$4.7M. For detailed data — including Titan Pharmaceuticals, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Titan Pharmaceuticals, Inc. (TTNP) stock price is $2.34. The stock is traded on NASDAQ under the ticker symbol TTNP. The 52-week range is $2.33 – $15.15.